MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devic, E.
Right arrow Articles by Kobilka, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devic, E.
Right arrow Articles by Kobilka, B.

Vol. 60, Issue 3, 577-583, September 2001

beta -Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from beta 1 and beta 2 Adrenoceptor Knockout Mice

Eric Devic, Yang Xiang, Dianna Gould, and Brian Kobilka

Howard Hughes Medical Institute, Stanford University Medical School, Stanford, California

The sympathetic nervous system modulates cardiac contractility and rate by activating beta -adrenergic receptors (beta AR) expressed on cardiac myocytes and specialized cells in the sinoatrial node and the conduction system. Recent clinical studies have suggested that beta -adrenergic receptors also play a role in cardiac remodeling that occurs in the pathogenesis of cardiomyopathy. Both beta 1 and beta 2 adrenergic receptors are expressed in human and murine hearts. We have examined the effect of beta AR activation on the spontaneous contraction rate of neonatal myocyte cultures from wild-type and beta  receptor knockout (KO) mice (beta 1AR-KO, beta 2AR-KO and beta 1beta 2AR-KO mice). Stimulation of the beta 1AR in beta 2AR-KO myocytes produces the greatest increase in contraction rate through a signaling pathway that requires protein kinase A (PKA) activation. In contrast, stimulation of the beta 2AR in beta 1AR-KO myocytes results in a biphasic effect on contraction rate with an initial increase in rate that does not require PKA, followed by a decrease in rate that involves coupling to a pertussis toxin sensitive G protein. A small isoproterenol-induced decrease in contraction rate observed in beta 1beta 2AR-KO myocytes can be attributed to the beta 3AR. These studies show that all three beta AR subtypes are expressed in neonatal cardiac myocytes, and the beta 1AR and beta 2AR couple to distinct signaling pathways.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
V. De Arcangelis, D. Soto, and Y. Xiang
Phosphodiesterase 4 and Phosphatase 2A Differentially Regulate cAMP/Protein Kinase A Signaling for Cardiac Myocyte Contraction under Stimulation of {beta}1 Adrenergic Receptor
Mol. Pharmacol., November 1, 2008; 74(5): 1453 - 1462.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Bruss, W. Richter, K. Horner, S.-L. C. Jin, and M. Conti
Critical Role of PDE4D in {beta}2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts
J. Biol. Chem., August 15, 2008; 283(33): 22430 - 22442.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
W. Xin, T. M. Tran, W. Richter, R. B. Clark, and T. C. Rich
Roles of GRK and PDE4 Activities in the Regulation of {beta}2 Adrenergic Signaling
J. Gen. Physiol., March 31, 2008; 131(4): 349 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang, V. De Arcangelis, X. Gao, B. Ramani, Y.-s. Jung, and Y. Xiang
Norepinephrine- and Epinephrine-induced Distinct 2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes
J. Biol. Chem., January 25, 2008; 283(4): 1799 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. P. Collis, S. Srivastava, W. A. Coetzee, and M. Artman
beta2-Adrenergic receptor agonists stimulate L-type calcium current independent of PKA in newborn rabbit ventricular myocytes
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2826 - H2835.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Wang, B. Lauffer, M. Von Zastrow, B. K. Kobilka, and Y. Xiang
N-Ethylmaleimide-Sensitive Factor Regulates beta2 Adrenoceptor Trafficking and Signaling in Cardiomyocytes
Mol. Pharmacol., August 1, 2007; 72(2): 429 - 439.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
O. G. Shcherbakova, C. M. Hurt, Y. Xiang, M. L. Dell'Acqua, Q. Zhang, R. W. Tsien, and B. K. Kobilka
Organization of {beta}-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
J. Cell Biol., February 12, 2007; 176(4): 521 - 533.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. M. DiPilato and J. Zhang
FRETting Mice Shed Light on Cardiac Adrenergic Signaling
Circ. Res., November 10, 2006; 99(10): 1021 - 1023.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. B. Pillai, M. Gupta, S. B. Rajamohan, R. Lang, J. Raman, and M. P. Gupta
Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1545 - H1553.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. He, M. Bellini, H. Inuzuka, J. Xu, Y. Xiong, X. Yang, A. M. Castleberry, and R. A. Hall
Proteomic Analysis of beta1-Adrenergic Receptor Interactions with PDZ Scaffold Proteins
J. Biol. Chem., February 3, 2006; 281(5): 2820 - 2827.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Germack and J. M. Dickenson
Induction of {beta}3-Adrenergic Receptor Functional Expression following Chronic Stimulation with Noradrenaline in Neonatal Rat Cardiomyocytes
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 392 - 402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. M. Ecker, C.-C. Lin, J. Powers, B. K. Kobilka, A. M. Dubin, and D. Bernstein
Effect of targeted deletions of {beta}1- and {beta}2-adrenergic-receptor subtypes on heart rate variability
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H192 - H199.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Seino and T. Shibasaki
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
Physiol Rev, October 1, 2005; 85(4): 1303 - 1342.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. G. Burniston, L.-B. Tan, and D. F. Goldspink
{beta}2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle
J Appl Physiol, April 1, 2005; 98(4): 1379 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Xiang, F. Naro, M. Zoudilova, S.-L. C. Jin, M. Conti, and B. Kobilka
Phosphodiesterase 4D is required for {beta}2 adrenoceptor subtype-specific signaling in cardiac myocytes
PNAS, January 18, 2005; 102(3): 909 - 914.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Veugelers, D. Wilkes, K. Burton, D. A. McDermott, Y. Song, M. M. Goldstein, K. La Perle, C. J. Vaughan, A. O'Hagan, K. R. Bennett, et al.
Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice
PNAS, September 28, 2004; 101(39): 14222 - 14227.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Barki-Harrington, C. Perrino, and H. A Rockman
Network integration of the adrenergic system in cardiac hypertrophy
Cardiovasc Res, August 15, 2004; 63(3): 391 - 402.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. J. Lohse, S. Engelhardt, and T. Eschenhagen
What Is the Role of {beta}-Adrenergic Signaling in Heart Failure?
Circ. Res., November 14, 2003; 93(10): 896 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Liang, S. Austin, Q. Hoang, and P. H. Fishman
Resistance of the Human {beta}1-Adrenergic Receptor to Agonist-mediated Down-regulation: ROLE OF THE C TERMINUS IN DETERMINING {beta}-SUBTYPE DEGRADATION
J. Biol. Chem., October 10, 2003; 278(41): 39773 - 39781.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Xiang and B. Kobilka
The PDZ-binding motif of the {beta}2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes
PNAS, September 16, 2003; 100(19): 10776 - 10781.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Hu, W. Chen, N. P. Martin, E. J. Whalen, R. T. Premont, and R. J. Lefkowitz
GIPC Interacts with the {beta}1-Adrenergic Receptor and Regulates {beta}1-Adrenergic Receptor-mediated ERK Activation
J. Biol. Chem., July 3, 2003; 278(28): 26295 - 26301.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Y. Xiang and B. K. Kobilka
Myocyte Adrenoceptor Signaling Pathways
Science, June 6, 2003; 300(5625): 1530 - 1532.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Conti, W. Richter, C. Mehats, G. Livera, J.-Y. Park, and C. Jin
Cyclic AMP-specific PDE4 Phosphodiesterases as Critical Components of Cyclic AMP Signaling
J. Biol. Chem., February 14, 2003; 278(8): 5493 - 5496.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xiang, E. Devic, and B. Kobilka
The PDZ Binding Motif of the beta 1 Adrenergic Receptor Modulates Receptor Trafficking and Signaling in Cardiac Myocytes
J. Biol. Chem., September 6, 2002; 277(37): 33783 - 33790.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xiang, V. O. Rybin, S. F. Steinberg, and B. Kobilka
Caveolar Localization Dictates Physiologic Signaling of beta 2-Adrenoceptors in Neonatal Cardiac Myocytes
J. Biol. Chem., September 6, 2002; 277(37): 34280 - 34286.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Genetically Modified Animals in Endocrinology
Endocr. Rev., August 1, 2002; 23(4): 594 - 597.
[Full Text] [PDF]


Home page
Sci SignalHome page
R.-P. Xiao
{beta}-Adrenergic Signaling in the Heart: Dual Coupling of the {beta}2-Adrenergic Receptor to Gs and Gi Proteins
Sci. Signal., October 16, 2001; 2001(104): re15 - re15.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics